MESO Competitors & Alternatives
Compare Mesoblast Ltd with similar stocks in the same industry
Biotechnology
MESO
Main Stock$14.17
Tradestie Score
49
Market Cap
$2.08B
Revenue Growth
15.3%
Analyst Upside
+147.0%
Top Competitors
233 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$38.93
|
$1.97B | - | 57 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$8.17
|
$1.92B | - | 58 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$86.38
|
$1.92B | - | 45 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$84.11
|
$1.90B | 510.6 | 56 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$32.10
|
$1.84B | - | 47 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$33.81
|
$1.81B | - | 51 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$5.71
|
$1.78B | - | 55 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$25.18
|
$1.78B | - | 55 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$18.92
|
$1.74B | - | 56 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$38.06
|
$1.68B | - | 57 | Compare |
More MESO Analysis
Data updated: Aug 02, 2026 | Industry: Biotechnology (SIC 2836)
233 stocks in this industry